![Becker Hewes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Becker Hewes
Hoofd Techniek/Wetenschap/O&O bij
DAMORA THERAPEUTICS, INC.
Vermogen: 7 M $ op 30-06-2026
Profiel
Becker Hewes is Chief Medical Officer bij Blueprint Medicines Corp. In zijn vorige carrière was Dr. Hewes Chief Medical Officer bij Repertoire Immune Medicines, Inc. en Executive Director-Translational Clinical Oncology bij Novartis Institutes for Biomedical Research, Inc. Hij promoveerde aan de Georgetown University School of Medicine en behaalde een bachelorgraad aan de Vanderbilt University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-01-2026 | 264.629 ( 0,43% ) | 7 M $ | 30-06-2026 |
Actieve functies van Becker Hewes
| Bedrijven | Functie | Begin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 05-01-2026 |
Eerdere bekende functies van Becker Hewes
| Bedrijven | Functie | Einde |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Hoofd Techniek/Wetenschap/O&O | 01-05-2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01-02-2017 |
| BLUEPRINT MEDICINES CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Becker Hewes
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
